Another day and another bunch of biotech company raising funds to fund their R&D programs (I won't name names here - but see announcements). How lucky are we that IXC is fully funded to revenue generation (with a positive result: > 55%), with some funds to spare to explore intracranial hypertension in TBI with a larger TAM.
- Forums
- ASX - By Stock
- Ann: First Patient Randomised in IIH EVOLVE Phase III Trial
Another day and another bunch of biotech company raising funds...
Featured News
Add IXC (ASX) to my watchlist
|
|||||
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.062 |
1 | 15500 | 0.061 |
1 | 150000 | 0.060 |
1 | 100000 | 0.052 |
1 | 60001 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 10000 | 1 |
0.069 | 16500 | 1 |
0.070 | 40000 | 1 |
0.076 | 888 | 1 |
0.083 | 4000 | 1 |
Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable